The Use of Prescription Drugs, Recreational Drugs, and “Soft Enhancers” for Cognitive Enhancement among Swiss Secondary School Students
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
The use of prescription or recreational drugs for cognitive enhancement (CE) is prevalent among students. However, the prevalence of CE among Swiss school students is unknown. We therefore performed a cross-sectional online survey including ≥ 16-year-old students from bridge-year schools (10th grade), vocational schools, and upper secondary schools (10th-12th grade) in the Canton of Zurich to investigate the prevalence of and motives for the use of prescription drugs, recreational drugs, and/or freely available soft enhancers for CE. A total of 1,139 students were included. Of these, 54.5% reported the use of prescription drugs (9.2%), recreational drugs including alcohol (6.2%), or soft enhancers (51.3%) explicitly for CE at least once in their lives. The last-year and last-month prevalence for CE considering all substances was 45.5% and 39.5%, respectively. Soft enhancers were the substances that were most commonly used (ever, last-year, and last-month, respectively), including energy drinks (33.3%, 28.4%, and 24.6%), coffee (29.8%, 25.1%, and 21.9%), and tobacco (12.6%, 9.3%, and 8.3%). CE with methylphenidate was less prevalent (4.0%, 2.8%, and 2.0%). However, the use of prescription drugs, alcohol, or illegal drugs for CE was reported by 13.3% of the participants. The most common motives for use were to stay awake and improve concentration. CE was more prevalent among students who reported higher levels of stress or performance pressure and students with psychiatric disorders. In conclusion, half of the school students had used a substance at least once in their lives to improve school performance. Soft enhancers were most commonly used. Prevalence rates were similar to those reported by Swiss university students, indicating that the use of prescription or recreational drugs for CE already occurs before starting higher education. Performance pressure, stress, and psychiatric disorders may be associated with CE.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
COHEN, S., & JANICKI‐DEVERTS, D. (2012) · Journal of Applied Social Psychology · doi:10.1111/j.1559-1816.2012.00900.x · Cited by 1,187
Misuse and Diversion of Stimulants Prescribed for ADHD: A Systematic Review of the Literature
WILENS, T. E., ADLER, L. A., ADAMS, J., SGAMBATI, S., ROTROSEN, J., SAWTELLE, R., UTZINGER, L., & FUSILLO, S. (2008) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e31815a56f1 · Cited by 824 · cited 1×
“In many previous studies [21,29], individuals with an ADD/ADHD or other psychiatric diagnosis that required medication were excluded to prevent a false prevalence assessment of drug use for CE.”
Psychostimulants and Cognition: A Continuum of Behavioral and Cognitive Activation
Wood, S., Sage, J. R., Shuman, T., & Anagnostaras, S. G. (2014) · Pharmacological Reviews · doi:10.1124/pr.112.007054 · Cited by 259
Cognitive enhancement by drugs in health and disease
Husain, M., & Mehta, M. A. (2011) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2010.11.002 · Cited by 241
Research works printed but not linked: 26
- LJ Maier, 2013, To dope or not to dope: neuroenhancement with prescription drugs and drugs of abuse among Swiss university students, PLoS One, 8, e77967, 10.1371/journal.pone.0077967 · DOI · Paper page
- S Vrecko, 2013, Just how cognitive is "cognitive enhancement"? On the significance of emotions in university students' experiences with study drugs, AJOB Neurosci, 4, 4, 10.1080/21507740.2012.740141 · DOI · Paper page
- M Schermer, 2009, The future of psychopharmacological enhancements: expectations and policies, Neuroethics, 2, 75, 10.1007/s12152-009-9032-1 · DOI
- KJ Schelle, 2014, Attitudes toward pharmacological cognitive enhancement: a review, Front Syst Neurosci, 8, 53, 10.3389/fnsys.2014.00053 · DOI
- AM Arria, 2008, Nonmedical use of prescription stimulants among college students: associations with attention-deficit-hyperactivity disorder and polydrug use, Pharmacotherapy, 28, 156, 10.1592/phco.28.2.156 · DOI · Paper page
- MJ Farah, 2014, Cognitive enhancement, WIREs Cogn Sci, 5, 95, 10.1002/wcs.1250 · DOI
- E Middendorff, 2012, Formen der Stresskompensation und Leistungssteigerung bei Studierenden. HISBUS-Befragung zur Verbreitung und zu Mustern von Hirndoping und Medikamentenmissbrauch, HIS: Forum Hochschule, 1
- LJ Maier, 2015, The use of prescription drugs and drugs of abuse for neuroenhancement in Europe: not widespread but a reality, Eur Psychologist
- D Repantis, 2010, Modafinil and methylphenidate for neuroenhancement in healthy individuals: a systematic review, Pharmacol Res, 62, 187, 10.1016/j.phrs.2010.04.002 · DOI · Paper page
- KS Bagot, 2014, Efficacy of stimulants for cognitive enhancement in non-attention deficit hyperactivity disorder youth: a systematic review, Addiction, 109, 547, 10.1111/add.12460 · DOI · Paper page
- R Ott, 2014, Neuroenhancement among Swiss students: a comparison of users and non-users, Pharmacopsychiatry, 47, 22
- C Forlini, 2009, Disagreements with implications: diverging discourses on the ethics of non-medical use of methylphenidate for performance enhancement, BMC Med Ethics, 10, 9, 10.1186/1472-6939-10-9 · DOI
- B Partridge, 2012, Public attitudes towards the acceptability of using drugs to treat depression and ADHD, Aust N Z J Psychiatry, 46, 958, 10.1177/0004867412450755 · DOI
- C Forlini, 2014, Knowledge, experiences and views of German university students toward neuroenhancement: an empirical-ethical analysis, Neuroethics
- B Partridge, 2012, A comparison of attitudes toward cognitive enhancement and legalized doping in sport in a community sample of Australian adults, Am J Bioethics Primary Res, 3, 81
- SE McCabe, 2009, Subtypes of nonmedical prescription drug misuse, Drug Alcohol Depend, 102, 63, 10.1016/j.drugalcdep.2009.01.007 · DOI · Paper page
- SE McCabe, 2005, Non-medical use of prescription stimulants among US college students: prevalence and correlates from a national survey, Addiction, 100, 96, 10.1111/j.1360-0443.2005.00944.x · DOI · Paper page
- SE McCabe, 2011, Medical misuse of controlled medications among adolescents, Arch Pediatr Adolesc Med, 165, 729, 10.1001/archpediatrics.2011.114 · DOI · Paper page
- AG Franke, 2010, Pharmacological neuroenhancement and brain doping: chances and risks, Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, 53, 853
- AG Franke, 2011, Non-medical use of prescription stimulants and illicit use of stimulants for cognitive enhancement in pupils and students, Germany. Pharmacopsychiatry, 44, 60, 10.1055/s-0030-1268417 · DOI · Paper page
- S Mache, 2012, Cognitive-enhancing substance use at German universities: frequency, reasons and gender differences, Wien Med Wochenschr, 162, 262, 10.1007/s10354-012-0115-y · DOI
- CI Ragan, 2013, What should we do about student use of cognitive enhancers? An analysis of current evidence, Neuropharmacology, 64, 588, 10.1016/j.neuropharm.2012.06.016 · DOI
- R de Jongh, 2008, Botox for the brain: enhancement of cognition, mood and pro-social behavior and blunting of unwanted memories, Neurosci Biobehav Rev, 32, 760, 10.1016/j.neubiorev.2007.12.001 · DOI · Paper page
- LJ Maier, 2015, Pharmacological cognitive enhancement in healthy individuals: a compensation for cognitive deficits or a question of personality?, PLoS One, 10, e0129805, 10.1371/journal.pone.0129805 · DOI
- SP Novak, 2007, The nonmedical use of prescription ADHD medications: results from a national Internet panel, Subst Abuse Treat Prev Policy, 2, 32, 10.1186/1747-597X-2-32 · DOI · Paper page
- LA Kroutil, 2006, Nonmedical use of prescription stimulants in the United States, Drug Alcohol Depend, 84, 135, 10.1016/j.drugalcdep.2005.12.011 · DOI · Paper page
Cited by
Hacking the Brain: Dimensions of Cognitive Enhancement
Dresler, M., Sandberg, A., Bublitz, C., Ohla, K., Trenado, C., Mroczko-Wąsowicz, A., Kühn, S., & Repantis, D. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00571 · Cited by 161
Dolder, P. C., Müller, F., Schmid, Y., Borgwardt, S. J., & Liechti, M. E. (2018) · Psychopharmacology · doi:10.1007/s00213-017-4650-5 · Cited by 117
Self-citationVorontsova-Wenger, O., Ghisletta, P., Ababkov, V., & Barisnikov, K. (2021) · Psychological Reports · doi:10.1177/0033294119899906 · Cited by 47
Grant, J. E., Redden, S. A., Lust, K., & Chamberlain, S. R. (2018) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000448 · Cited by 39
Dolder, P. C., Strajhar, P., Vizeli, P., Odermatt, A., & Liechti, M. E. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4849-0 · Cited by 34
Self-citation
Metadata
- Authors
- Liakoni, E., Schaub, M. P., Maier, L. J., Glauser, G.-V., & Liechti, M. E.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-10-27
- Volume
- 10
- Issue
- 10
- Pages
- e0141289
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2339542115
- Cited by
- 54
- References
- 4
- FWCI
- 3.87
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Use of Prescription Drugs, Recreational Drugs, and “Soft Enhancers” for Cognitive Enhancement among Swiss Secondary School Students. https://app.cochat.ai/papers/10.1371/journal.pone.0141289
- The paper
- Liakoni, E., Schaub, M. P., Maier, L. J., Glauser, G.-V., & Liechti, M. E. (2015). The Use of Prescription Drugs, Recreational Drugs, and “Soft Enhancers” for Cognitive Enhancement among Swiss Secondary School Students. PLOS ONE. https://doi.org/10.1371/journal.pone.0141289
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.